Please login to the form below

Not currently logged in
Email:
Password:

Former Sanofi SVP to chair Idera

James Geraghty joins the firm with 20 years biotech experience from Genzyme

James Geraghty, IderaIdera Pharmaceuticals has named James Geraghty as the company's new chairman.

Idera specialises in developing toll-like receptors (TLRs) for autoimmune and inflammatory conditions and will benefit from Geraghty's extensive career in the life sciences industry, which includes 20 years ion senior roles at leading biotech Genzyme.

He was later appointed senior VP, North America strategy at Sanofi after the company took over Genzyme in 2011, before leaving earlier this year to become entrepreneur-in-residence at venture capital firm Third Rock Ventures.

“I believe that the addition of Jim and his extensive experience comes at an ideal moment, and we look forward to his guidance and contributions as we advance our programmes toward later stage development,” said Dr Sudhir Agrawal, CEO of Idera.

These programmes involve the company's TLR antagonist drug candidates, which Idera says have shown proof-of-concept in clinical trials and are set for further studies in psoriasis and other conditions.

19th July 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...